Summer program gives undergraduates a taste of research life

The Bowers Undergraduate Research Experience is a 10-week summer program where Cornell undergraduates are paired with one of nearly 40 faculty mentors and their doctoral students to tackle a specific research project.

Josh Gully ’83 and partners build investment firm for ultra-wealthy

The newest episode of “Startup Cornell,” a podcast hosted by Entrepreneurship at Cornell, features Josh Gully ’83, managing director of NewEdge Wealth.

Around Cornell

David Reiss joins Cornell Law School and Cornell Tech faculties

On July 1, Cornell Law School and Cornell Tech welcomed David Reiss to their faculties as clinical professor of law and research director of the Blassberg-Rice Center for Entrepreneurship Law.

Around Cornell

SEG grants fund summer internships, research projects

More than 100 Arts and Sciences students were awarded Summer Experience Grants, which help students pay for housing, food, transportation and other expenses while they undertake minimally paid or unpaid summer internships or positions.

Around Cornell

General anesthetic may lead to new epilepsy treatments

Propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a new study.

Preclinical study explores approved drug for ovarian cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.

Medicaid enrollees struggle to find psychiatric care

Many people enrolled in Medicaid who require psychiatric care have difficulty accessing clinicians in a timely manner despite the higher need in this population, according to a study by researchers at Weill Cornell Medicine.

Medicaid policies increase diversity in cancer clinical trials

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.

Blood test may guide use of multiple myeloma immunotherapy

A simple blood test that measures the number of lymphocytes may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy.